| Dateline Resources Limited (DTR) ORDINARY FULLY PAID |
Materials |
$550 |
Pause in Trading
|
29 Aug 2025 9:56AM |
$0.265 |
$0.140 |
fallen by
47.17%
|
|
DTR - Price-sensitive ASX Announcement
Full Release
Key Points
- Temporary pause in trading for Dateline Resources Limited.
- Trading pause pending further announcement.
- ASX Listings Compliance managed the release.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Thorney Opportunities Ltd (TOP) ORDINARY FULLY PAID |
Financials |
$92 |
Update - Notification of buy-back - TOP
|
29 Aug 2025 9:55AM |
$0.675 |
$0.550 |
fallen by
18.52%
|
|
| Aeris Resources Limited (AIS) ORDINARY FULLY PAID |
Materials |
$569 |
Application for quotation of securities - AIS
|
29 Aug 2025 9:54AM |
$0.235 |
$0.380 |
risen by
61.70%
|
|
| Berkeley Energia Limited (BKY) ORDINARY FULLY PAID |
Energy |
$216 |
Change in substantial holding
|
29 Aug 2025 9:53AM |
$0.530 |
$0.485 |
fallen by
8.49%
|
|
| Centaurus Metals Limited (CTM) ORDINARY FULLY PAID |
Materials |
$289 |
Ceasing to be a substantial holder
|
29 Aug 2025 9:53AM |
$0.360 |
$0.510 |
risen by
41.67%
|
|
| RPMGlobal Holdings Limited (RUL) ORDINARY FULLY PAID |
Information Technology |
- |
Trading Halt
|
29 Aug 2025 9:53AM |
$3.770 |
$4.990 |
risen by
32.36%
|
|
RUL - Price-sensitive ASX Announcement
Full Release
Key Points
- RPMGlobal Holdings Limited requested a trading halt.
- The trading halt is pending a significant acquisition proposal.
- Halt remains until 2 September 2025 or an earlier announcement.
- The company ensures compliance with disclosure obligations.
- RPM is a global leader in mining software solutions.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Staude Capital Global Value Fund Limited (GVF) ORDINARY FULLY PAID |
Financials |
$281 |
Appendix 4E and 2025 Annual Report
|
29 Aug 2025 9:52AM |
$1.410 |
$1.385 |
fallen by
1.77%
|
|
GVF - Price-sensitive ASX Announcement
Full Release
Key Points
- Staude Capital Global Value Fund Limited (GVF) reported an operating profit after tax of $24,254,424 for the year ended 30 June 2025.
- The company's adjusted pre-tax NTA increased by 15.8% during FY2025, with shareholder total returns reported at 19.2%.
- A fully franked final dividend for FY2025 of 3.3 cents per share is declared, to be paid on 12 November 2025.
- GVF's dividend reinvestment plan (DRP) allows participants to receive dividends as newly issued shares if the share price is above the NTA per share.
- The company successfully completed a placement of shares to wholesale investors in June 2025, raising a total of $16,908,079.
- The investment management agreement was updated with Staude Capital Pty Limited, replacing Mirabella Financial Services LLP as of 1 May 2025.
- GVF shares traded at an average 1.9% discount to its pre-tax NTA over FY2025.
- Significant performance contributors included investments in global share and credit markets.
- GVF's net tangible asset backing per share before tax was $1.3613, and $1.2780 after tax as of 30 June 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Staude Capital Global Value Fund Limited (GVF) ORDINARY FULLY PAID |
Financials |
$281 |
Appendix 4E and 2025 Annual Report
|
29 Aug 2025 9:52AM |
$1.410 |
$1.385 |
fallen by
1.77%
|
|
GVF - Price-sensitive ASX Announcement
Full Release
Key Points
- Staude Capital Global Value Fund Limited reported a net profit of AUD 24,254,424 for the financial year ending 30 June 2025.
- The company's total assets amounted to AUD 273,632,725, while total liabilities were AUD 33,382,444 as of 30 June 2025.
- The fund's annualized investment returns since inception stood at 11.4% as of June 2025.
- The issuance of shares on a wholesale placement raised AUD 16,908,080 during the year.
- Total equity of the company was reported at AUD 240,250,281 as of 30 June 2025.
- Basic and diluted earnings per share were recorded at 13.85 cents for the year.
- The fund's management fees amounted to AUD 3,295,154, and performance fees were AUD 3,016,852 for the year.
- A significant contributor to the fund's performance in FY2025 was the London-listed Amedeo Air Four Plus fund.
- The company's total income, including net realized and unrealized gains, was AUD 46,919,446 for the financial year.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| MedAdvisor Limited (MDR) ORDINARY FULLY PAID |
Health Care |
- |
FY25 Financial Results
|
29 Aug 2025 9:51AM |
$0.056 |
$0.022 |
fallen by
60.71%
|
|
MDR - Price-sensitive ASX Announcement
Full Release
Key Points
- FY25 revenue from continuing operations decreased to $63.0 million.
- Gross profit of $32.9 million with a 52.3% gross margin.
- EBITDA before impairment recorded a $10.7 million loss.
- Intangible assets were impaired by $46.5 million.
- Successful $7.7 million capital raise.
- Cost-out program targeting $12.8 million savings between FY24 to FY26.
- Sale of ANZ business to Jonas Software AUS for up to $42.35 million.
- Focus on restructuring and scaling US operations in FY26.
- Consideration of the sale of US business as part of strategic review.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| MedAdvisor Limited (MDR) ORDINARY FULLY PAID |
Health Care |
- |
FY25 Financial Results
|
29 Aug 2025 9:51AM |
$0.056 |
$0.022 |
fallen by
60.71%
|
|
MDR - Price-sensitive ASX Announcement
Full Release
Key Points
- FY25 group revenue of $63.0 million, down 36.0% from FY24.
- EBITDA before impairment recorded a $10.7 million loss.
- Intangible assets impaired by $46.5 million.
- Successful $7.7 million capital raise.
- Cost-out program to deliver $12.8 million in savings by FY26.
- Transformation 360° initiative with over 70% US platform development complete.
- Sale of ANZ business operations for $35 million plus earn-out.
- Focus on restructuring US commercial operations and platform development.
- Withdrawal of FY26 revenue guidance due to market uncertainties.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Alterity Therapeutics Limited (ATH) ORDINARY FULLY PAID |
Health Care |
$146 |
Appendix 4E and 2025 Annual Report
|
29 Aug 2025 9:49AM |
$0.012 |
$0.670 |
risen by
5,483.33%
|
|
ATH - Price-sensitive ASX Announcement
Full Release
Key Points
- Issued 3,636,363,636 ordinary shares at AUD 0.011 per share.
- Raised approximately AUD 40 million through a two-tranche placement.
- Recorded a comprehensive loss of AUD 12.1 million for the year ending June 30, 2025.
- Research and development expenses totaled AUD 14.4 million.
- Increased issued capital to 9,127,370,686 fully paid ordinary shares.
- Net cash inflow of approximately AUD 20.7 million.
- Significant options activity with numerous issuances and expirations.
- Corporate directory lists key directors and executives.
- Shareholder information details equity securities distribution.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Alpha HPA Limited (A4N) ORDINARY FULLY PAID |
Materials |
$936 |
2025 Sustainability Performance Report
|
29 Aug 2025 9:49AM |
$0.970 |
$0.645 |
fallen by
33.51%
|
|
| Accent Resources N.L. (ACS) ORDINARY FULLY PAID |
Materials |
$12 |
Response to ASX Aware Query
|
29 Aug 2025 9:49AM |
$0.006 |
$0.025 |
risen by
316.67%
|
|
ACS - Price-sensitive ASX Announcement
Full Release
Key Points
- Testwork completed on 23 July 2025.
- Awareness of results at 1pm AEST on 23 July 2025.
- No immediate announcement due to incremental and confirmatory nature.
- Results not considered to influence securities' price or value.
- Market sensitive flag used for cautious dissemination.
- Compliance with ASX Listing Rule 3.1 confirmed.
- Board authorized responses to ASX.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Accent Resources N.L. (ACS) ORDINARY FULLY PAID |
Materials |
$12 |
Response to ASX Aware Query
|
29 Aug 2025 9:49AM |
$0.006 |
$0.025 |
risen by
316.67%
|
|
ACS - Price-sensitive ASX Announcement
Full Release
Key Points
- Metallurgical testwork results were incremental and confirmatory.
- Information did not meet the materiality threshold under Listing Rule 3.1.
- No immediate announcement was required before 4 August 2025.
- Results were marked 'market sensitive' on ASX release.
- Company maintains compliance with ASX disclosure rules.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Bubs Australia Limited (BUB) ORDINARY FULLY PAID |
Consumer Staple |
$75 |
FY25 Results Presentation
|
29 Aug 2025 9:49AM |
$0.165 |
$0.084 |
fallen by
49.09%
|
|
| Bathurst Resources Limited (BRL) ORDINARY FULLY PAID |
Materials |
$113 |
FY25 Results presentation
|
29 Aug 2025 9:49AM |
$0.740 |
$0.470 |
fallen by
36.49%
|
|
BRL - Price-sensitive ASX Announcement
Full Release
Key Points
- FY25 results showed increased revenue and EBITDA from higher sales volumes.
- BRL's Buller and Tenas projects are key growth focuses with streamlined approvals.
- The Buller Project aims for a low-capex startup by 2027.
- The Stockton project is significant for maintaining long-term production.
- Crown Mountain project offers substantial growth optionality.
- Commitment to high-quality metallurgical coal for steelmaking.
- BRL has made significant contributions to the New Zealand economy.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Bathurst Resources Limited (BRL) ORDINARY FULLY PAID |
Materials |
$113 |
FY25 Results presentation
|
29 Aug 2025 9:49AM |
$0.740 |
$0.470 |
fallen by
36.49%
|
|
BRL - Price-sensitive ASX Announcement
Full Release
Key Points
- Profitable operations at BT Mining JV and Takitimu
- Successful capital raise of AUD $34 million
- Consolidated FY25 revenue of NZD $268 million
- Challenges due to Tawhai Tunnel closure
- Buller project to support production for 10+ years
- Tenas project undergoing environmental assessments
- Litigation with Talley’s Group Limited ongoing
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| MedAdvisor Limited (MDR) ORDINARY FULLY PAID |
Health Care |
- |
Appendix 4E Preliminary Final Report FY25
|
29 Aug 2025 9:47AM |
$0.056 |
$0.022 |
fallen by
60.71%
|
|
MDR - Price-sensitive ASX Announcement
Full Release
Key Points
- MedAdvisor Limited incurred a significant loss from continuing operations at $63.3 million.
- Revenue from continuing operations dropped to $62.9 million.
- Profit from discontinuing operations was recorded.
- Significant impairment of assets noted.
- Decrease in total equity to a deficit position.
- Post reporting period sale of ANZ business reducing debt.
- Financial statements are under audit.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| MedAdvisor Limited (MDR) ORDINARY FULLY PAID |
Health Care |
- |
Appendix 4E Preliminary Final Report FY25
|
29 Aug 2025 9:47AM |
$0.056 |
$0.022 |
fallen by
60.71%
|
|
MDR - Price-sensitive ASX Announcement
Full Release
Key Points
- Significant loss after income tax of $60,208,977.
- Total comprehensive income deficit of $60,599,111.
- Net liability position of $1,617,738 as of June 30, 2025.
- Revenue from health programs decreased to $63 million.
- Sale of MedAdvisor International Pty Ltd as a 'discontinuing operation'.
- Full impairment of US operations' intangible assets.
- Net cash decrease of $5.2 million, with ending cash at $10.3 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| 4DMedical Limited (4DX) ORDINARY FULLY PAID |
Health Care |
$2,540 |
FY2025 Full year results
|
29 Aug 2025 9:46AM |
$0.480 |
$4.250 |
risen by
785.42%
|
|
4DX - Price-sensitive ASX Announcement
Full Release
Key Points
- SaaS products delivered at 388 sites globally, 60% growth year-on-year.
- Operating revenue increased to $5.9 million, up 56% from FY2024.
- FDA 510(k) submission for CT:VQ™ software.
- Strategic reseller agreement with Philips.
- Secured $10 million investment from Pro Medicus.
- Commercial progress in the U.S. and Australia.
- Focus on sustainable growth and cost efficiencies.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| 4DMedical Limited (4DX) ORDINARY FULLY PAID |
Health Care |
$2,540 |
FY2025 Full year results
|
29 Aug 2025 9:46AM |
$0.480 |
$4.250 |
risen by
785.42%
|
|
4DX - Price-sensitive ASX Announcement
Full Release
Key Points
- 4DMedical achieved significant growth in FY2025 with 388 SaaS product sites globally, up 60% year-on-year.
- The company produced over 74,000 scans in Q4 FY2025, a 35% increase quarter-on-quarter.
- 4DMedical's operating revenue for FY2025 was $5.9 million, up 56% from FY2024.
- CT:VQ™ software, a non-contrast lung imaging tool, is undergoing FDA 510(k) clearance.
- A strategic partnership with Philips aims to enhance care for veterans with respiratory diseases.
- 4DMedical secured a $10 million strategic investment from Pro Medicus.
- Contracts were signed with notable clients in the U.S. and Australia, including Integral Diagnostics and UChicago Medicine.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| BETR Entertainment Limited (BBT) ORDINARY FULLY PAID |
Consumer Discretionary |
$188 |
TOV: BBT Panel Receives Application
|
29 Aug 2025 9:46AM |
$0.300 |
$0.180 |
fallen by
40%
|
|
BBT - Price-sensitive ASX Announcement
Full Release
Key Points
- Application by BETR Entertainment Limited regarding PointsBet Holdings Limited.
- PointsBet faces takeover offers from MIXI Australia Pty Ltd and BETR.
- BETR holds a 19.6% interest in PointsBet.
- BETR disputes PointsBet board's vesting of performance rights.
- Request for interim and final orders to influence ongoing takeover bids.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pointsbet Holdings Limited (PBH) ORDINARY FULLY PAID |
Consumer Discretionary |
$339 |
TOV: BBT Panel Receives Application
|
29 Aug 2025 9:46AM |
$1.260 |
$0.975 |
fallen by
22.62%
|
|
PBH - Price-sensitive ASX Announcement
Full Release
Key Points
- PointsBet Holdings Limited is under two takeover offers.
- Betr holds a 19.6% interest in PointsBet.
- PointsBet board's discretion on performance rights vesting is contested.
- Betr claims the decision affects market competitiveness.
- Betr seeks to prevent further vesting and challenges new share issuance's impact on MIXI's voting power.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| BETR Entertainment Limited (BBT) ORDINARY FULLY PAID |
Consumer Discretionary |
$188 |
TOV: BBT Panel Receives Application
|
29 Aug 2025 9:46AM |
$0.300 |
$0.180 |
fallen by
40%
|
|
BBT - Price-sensitive ASX Announcement
Full Release
Key Points
- Betr Entertainment Limited (ASX: BBT) has submitted an application to the Takeovers Panel regarding PointsBet Holdings Limited.
- PointsBet is dealing with two competing takeover offers: a cash offer from MIXI Australia and a reverse takeover offer from betr.
- Betr holds a 19.6% interest in PointsBet shares.
- PointsBet's board exercised discretion to vest Performance Rights, which betr deems inappropriate.
- Betr challenges the vesting of Performance Rights as it impacts the competitive market for PointsBet shares.
- Betr seeks interim orders to halt further vesting of options and performance rights by PointsBet.
- Betr requests final orders for the cancellation of newly issued shares and reissuance of performance rights.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pointsbet Holdings Limited (PBH) ORDINARY FULLY PAID |
Consumer Discretionary |
$339 |
TOV: BBT Panel Receives Application
|
29 Aug 2025 9:46AM |
$1.260 |
$0.975 |
fallen by
22.62%
|
|
PBH - Price-sensitive ASX Announcement
Full Release
Key Points
- Takeovers Panel received an application from betr Entertainment Limited regarding PointsBet Holdings Limited.
- PointsBet is subject to two competing takeover offers: from MIXI Australia Pty Ltd and betr.
- Concerns raised about PointsBet board accelerating the vesting of performance rights.
- betr claims the board's actions result in unfair competitive conditions.
- betr seeks orders to prevent further acceleration of options or rights and to not count the newly issued shares towards MIXI's voting power.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
